319 related articles for article (PubMed ID: 23374751)
1. MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.
Torres M; Guiton R; Lacroix-Lamandé S; Ryffel B; Leman S; Dimier-Poisson I
J Neuroinflammation; 2013 Feb; 10():19. PubMed ID: 23374751
[TBL] [Abstract][Full Text] [Related]
2. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
[TBL] [Abstract][Full Text] [Related]
4. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
[TBL] [Abstract][Full Text] [Related]
5. T cell expression of MyD88 is required for resistance to Toxoplasma gondii.
LaRosa DF; Stumhofer JS; Gelman AE; Rahman AH; Taylor DK; Hunter CA; Turka LA
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3855-60. PubMed ID: 18308927
[TBL] [Abstract][Full Text] [Related]
6. Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade.
Snyder LM; Doherty CM; Mercer HL; Denkers EY
PLoS Pathog; 2021 Oct; 17(10):e1009970. PubMed ID: 34597344
[TBL] [Abstract][Full Text] [Related]
7. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.
Mun HS; Aosai F; Norose K; Chen M; Piao LX; Takeuchi O; Akira S; Ishikura H; Yano A
Int Immunol; 2003 Sep; 15(9):1081-7. PubMed ID: 12917260
[TBL] [Abstract][Full Text] [Related]
8. Immediate Interferon Gamma Induction Determines Murine Host Compatibility Differences between Toxoplasma gondii and Neospora caninum.
Coombs RS; Blank ML; English ED; Adomako-Ankomah Y; Urama IS; Martin AT; Yarovinsky F; Boyle JP
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 32014892
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Infection Immunity Regulated by
Hwang YS; Shin JH; Yang JP; Jung BK; Lee SH; Shin EH
Front Immunol; 2018; 9():158. PubMed ID: 29459868
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
[TBL] [Abstract][Full Text] [Related]
11. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
[TBL] [Abstract][Full Text] [Related]
12. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent.
Thouvenin M; Candolfi E; Villard O; Klein JP; Kien T
Parassitologia; 1997 Dec; 39(4):279-83. PubMed ID: 9802080
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.
Scanga CA; Aliberti J; Jankovic D; Tilloy F; Bennouna S; Denkers EY; Medzhitov R; Sher A
J Immunol; 2002 Jun; 168(12):5997-6001. PubMed ID: 12055206
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
15. Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.
Sa Q; Ochiai E; Tiwari A; Perkins S; Mullins J; Gehman M; Huckle W; Eyestone WH; Saunders TL; Shelton BJ; Suzuki Y
J Immunol; 2015 Aug; 195(3):796-800. PubMed ID: 26091720
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 and Galectin-9 May Differently Regulate the Expressions of Microglial M1/M2 Markers and T Helper 1/Th2 Cytokines in the Brains of Genetically Susceptible C57BL/6 and Resistant BALB/c Mice Following Peroral Infection With
Liu J; Huang S; Lu F
Front Immunol; 2018; 9():1648. PubMed ID: 30108583
[TBL] [Abstract][Full Text] [Related]
17. Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis.
Wen X; Kudo T; Payne L; Wang X; Rodgers L; Suzuki Y
J Interferon Cytokine Res; 2010 Sep; 30(9):653-60. PubMed ID: 20626297
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.
Suzuki Y; Sa Q; Gehman M; Ochiai E
Expert Rev Mol Med; 2011 Oct; 13():e31. PubMed ID: 22005272
[TBL] [Abstract][Full Text] [Related]
19. TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii.
López-Yglesias AH; Camanzo E; Martin AT; Araujo AM; Yarovinsky F
PLoS Pathog; 2019 Jun; 15(6):e1007872. PubMed ID: 31194844
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
